Journal of Experimental Medicine, Vol 174, 1607-1615, Copyright © 1991 by Rockefeller University Press

ARTICLES

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

E Mellins, S Kempin, L Smith, T Monji and D Pious
Department of Pediatrics, University of Washington 98105.

We have previously described a set of mutants (16.23-selected mutants) of a B lymphoblastoid cell line that are defective in the presentation of intact proteins to class II-restricted T cells, but effectively present immunogenic peptides. The mutations in these mutants are recessive in somatic cell hybrids and are not in Class II structural genes. Here, we report on a unique mutant, 5.2.4, in which a similar defect in class II-restricted antigen presentation has occurred in association with a one-megabase homozygous deletion in the class II region of the major histocompatibility complex (MHC). The defects in class II presentation among three of the 16.23-selected mutants, and between these mutants and 5.2.4, are noncomplementary in somatic cell hybrids. This suggests that the class II presentation-defective phenotype in all four mutants results from lesions in a single MHC- linked gene, a conclusion strengthened by the finding that in a hybrid made with a second, unrelated MHC deletion mutant, T2, the class II presentation defect in a 16.23-selected mutant is also not complemented. Mutant 5.2.4, in addition to its class II presentation defect, is also defective in surface expression of MHC class I molecules, most likely because its deletion encompasses the peptide supply factor 1 gene, whose function is known to be required for normal abundance of cell surface class I molecules. However, the surface abundance of class I molecules is normal in the 16.23-selected mutants, suggesting that the lesions affecting class I surface abundance and class II presentation result from mutations in different genes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Fallang, L.-E., Roh, S., Holm, A., Bergseng, E., Yoon, T., Fleckenstein, B., Bandyopadhyay, A., Mellins, E. D., Sollid, L. M. (2008). Complexes of Two Cohorts of CLIP Peptides and HLA-DQ2 of the Autoimmune DR3-DQ2 Haplotype Are Poor Substrates for HLA-DM. J. Immunol. 181: 5451-5461 [Abstract] [Full Text]  
• Menges, P. R., Jenks, S. A., Bikoff, E. K., Friedmann, D. R., Knowlden, Z. A. G., Sant, A. J. (2008). An MHC Class II Restriction Bias in CD4 T Cell Responses toward I-A Is Altered to I-E in DM-Deficient Mice. J. Immunol. 180: 1619-1633 [Abstract] [Full Text]  
• Hornell, T. M. C., Burster, T., Jahnsen, F. L., Pashine, A., Ochoa, M. T., Harding, J. J., Macaubas, C., Lee, A. W., Modlin, R. L., Mellins, E. D. (2006). Human Dendritic Cell Expression of HLA-DO Is Subset Specific and Regulated by Maturation. J. Immunol. 176: 3536-3547 [Abstract] [Full Text]  
• Doebele, R. C., Pashine, A., Liu, W., Zaller, D. M., Belmares, M., Busch, R., Mellins, E. D. (2003). Point Mutations in or Near the Antigen-Binding Groove of HLA-DR3 Implicate Class II-Associated Invariant Chain Peptide Affinity as a Constraint on MHC Class II Polymorphism. J. Immunol. 170: 4683-4692 [Abstract] [Full Text]  
• Schubert, L. A., Cron, R. Q., Cleary, A. M., Brunner, M., Song, A., Lu, L.-S., Jullien, P., Krensky, A. M., Lewis, D. B. (2002). A T Cell-specific Enhancer of the Human CD40 Ligand Gene. J. Biol. Chem. 277: 7386-7395 [Abstract] [Full Text]  
• van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L., Neefjes, J. (2001). Regulation of MHC Class II Antigen Presentation by Sorting of Recycling HLA-DM/DO and Class II within the Multivesicular Body. J. Immunol. 167: 884-892 [Abstract] [Full Text]  
• van Ham, M., van Lith, M., Lillemeier, B., Tjin, E., Gruneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K., Roucard, C., Trowsdale, J., Ottenhoff, T., Pappin, D., Neefjes, J. (2000). Modulation of the Major Histocompatibility Complex Class II-Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do. JEM 191: 1127-1136 [Abstract] [Full Text]  
• Groh, V., Steinle, A., Bauer, S., Spies, T. (1998). Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial T Cells. Science 279: 1737-1740 [Abstract] [Full Text]  
• Fling, S. P., Rak, J., Muczynski, K. A., Arp, B., Pious, D. (1997). Novel Mutants Define Genes Required for the Expression of Human Histocompatibility Leukocyte Antigen DM: Evidence for Loci on Human Chromosome 6p. JEM 186: 1469-1480 [Abstract] [Full Text]  
• Lightstone, L., Hargreaves, R., Bobek, G., Peterson, M., Aichinger, G., Lombardi, G., Lechler, R. (1997). In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94: 5772-5777 [Abstract] [Full Text]  
• Denzin, L. K., Hammond, C., Cresswell, P. (1996). HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules. JEM 184: 2153-2166 [Abstract] [Full Text]  
• Grandea, A. G. III, Spies, T., Androlewicz, M. J., Athwal, R. S., Geraghty, D. E. (1995). Dependence of Peptide Binding by MHC Class I Molecules on Their Interaction with TAP. Science 270: 105-108 [Abstract]  
• Sette, A, Ceman, S, Kubo, R., Sakaguchi, K, Appella, E, Hunt, D., Davis, T., Michel, H, Shabanowitz, J, Rudersdorf, R, et, al. (1992). Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258: 1801-1804 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS